Novel drug delivery systems based on polymeric nanoparticles and microspheres as well as liposomes have demonstrated great potential in enhancing therapeutic effects of drugs. Biodegradable polymers with strong biocompatibilities such as poly(lactic-co-glycolic acid) (PLGA), polylactic acid (PLA), and polycaprolactone (PCL) have been widely used in developing particulate drug delivery systems. Active pharmaceutical ingredients (APIs), whether small molecules or biologic compounds, can be encapsulated into microspheres and nanoparticles or attached to a particle’s surface for specific drug delivery applications such as sustained release, targeted drug delivery, and protection of APIs from premature degradation. Upon administrating drug-loaded biodegradable nanoparticles and microparticles, the biocompatable polymer degrades in vivo by hydrolysis of the ester backbone into non-toxic products. The drug release rate can be modulated by selecting the right type of polymer and adjusting the encapsulation process.
Tech Spotlight: Degradex® Microspheres and Nanoparticles for Drug Delivery Research and Formulation Development
FAQs: Drug Delivery
Handbook: Nanomaterial Bioconjugation Techniques
Material Matters 14.1: Microfluidic-Assisted Manufacturing of Materials for Nanomedicine
Material Matters 14.3: Smart Oligonucleotide Delivery by Multifunctional Block Copolymers
Material Matters 14.3: Nanoparticle-Based Drug and Gene Delivery for Tumor Targeting
Material Matters 14.3: Applications of Glucose Polymers in the Synthesis of Diagnostic and Drug Delivery Nanoparticles
Material Matters 14.2 Fluorescent Nanomaterials for Bioimaging: Considerations of Particle Brightness, Photostability, and Size
Technical Article: Dendrons and Hyperbranched Polymers: Multifunctional Tools for Materials Chemistry
Article: RAFT Polymerization Procedures
Article: RAFT Choosing the Right Agent to Achieve Controlled Polymerization
Article: Universal (Switchable) RAFT Agents for Well-Defined Block Copolymers
Article: Block Copolymer Synthesis Using a Nitroxide-mediated Radical Polymerization (NMP) Approach
Article: RAFT Agents for Making Well-Defined Functionalized Polymers
We offer Degradex® PLGA- and PCL-based plain and fluorescent microspheres and nanoparticles. Plain PLGA microspheres and PLGA nanoparticles can be used in drug and RNA delivery formulations as control agents or be used to test system compatibility before loading an API into the carrier. Fluorescent nanoparticles and microspheres can be used in numerous imaging and diagnostic applications such as:
Both plain and fluorescent particles have surfaces functionalized with carboxyl groups that allow for covalent attachment of proteins, peptides, antibodies, antigens, and small molecules.
Degradex® poly(lactic-co-glycolic acid) (PLGA) and polycaprolactone microspheres and nanoparticles are biodegradable and biocompatible polymeric particles that are available in a range of 100 nm to 50 μm in diameter. Degradex® particles can be used to confirm drug carrier compatibility prior to formulation development. In addition, surface functionalization of the particles with carboxyl groups enables Degradex® particles to be used for targeted therapy and increased circulation time.
Our fluorescent poly(lactic-co-glycolic acid) (PLGA) particles with excitation/emission wavelengths of 460/500, 530/582, 644/665 and 780/820 nm allow easy visualization of particles in bioimaging and diagnostic applications, including cell tracking, phagocytosis studies, fluorescent microscopy, and drug discovery. We offer green, orange, red and near-IR fluorescent PLGA particles in a range of sizes from 100 nm to 50 μm in diameter.
To continue reading please sign in or create an account.Don't Have An Account?